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Introduction 
Infection is disease which causes by infection 
agent namely bacteria, virus, fungi and protozoa. One of 
the causes of infection disease is bacteria. 
Enterobacteriacea is Gram-negative bacteria which the 
rod is located in the human intestine; one of the examples 
is Escherichia  [1]. Escherichia coli are the pathogen 
bacteria as the cause of morbidity and mortality [2]. 
The interesting pathogen group with several anti-
microbe agents which shows the improvement of 
resistance level is E coli. Resistance of ciprofloxacin only 
4,1% in the first year and continue to increase become 
31,8% after 10 years. Amino-glycosides is also shows the 
slower increase of resistance, but it still consistence, from 
1999 (tobramycin, resistance on 1,5%) to 2007 (10,3%). 
The resistance of cefepime to E. coli strain, first time shows 
in 2004 (0,4) and faster increase become 5,1% only in 5 
years (ESBL). Between Klebsiella spp. Isolate, 
carbapenem resistance is rarely observed before the year of 
2003, but after the its existence, the resistance level is 
quickly increased to almost 8% in 2007 before falls to 4.3% 
in 2008 related with the intervention of local infection 
control. The increase of resistance on fluoroquinolonei and 
Amino-glycosides resistance is recorded in 2005 [3]. 
The usage of anti-bacteria which is not widely 
indicated, repeated and in the long current time can causes 
the existence of resistance on anti-bacteria, namely 
resistance on resistance to carbapenem class antibiotics. 
Resistance on class antibiotic occurs of the improvement 
and become a phenomenon to watch out for at this time. 
This phenomenon has proven by researcher of a hospital or 
by the analysis with using National database. According to 
the data from European Centre for Disease Prevention and 
Control (ECDC) in 2009 to 2012 occurs the increase of 
infection cases to the blood which causes by Klebsiella 
pneumonia that resistance of Carbapenem occurs the 
improvement to 5% in 5 different countries [3]. 
According to [4], OXA-48 is β-D-Glucopyranose 
which is not inhibited by clavulanic acid, tazobactam and 
sulbactam, because the activity is possibly inhibited in-
vitro by NaCl. Some b-lactamase enzyme is hydrolyzing 
carbapenem and it defined as carbapenem-hydrolysing, as 
D class of β-lactamase (CHDLs). Isolate OXA-48 
produced isolate which have the ability of resistance on 
many medicines and shows the higher resistance for the 
entire β-lactam, including broad spectrum cephalosporins, 
cephamycins, monobacton and carbapenems, gene OXA-
48 found in plasmid.  
Gene bla OXA-48 have the relationship on 
sequence insertion IS1999 to K.pneumoniae, then 
expressed β-lactamase [5]. Has proven that blaOXA-48 is 
the part of composite transposon called Tn1999 and made 
of two copies IS1999 which grouped by this gene. 
Antibiotic resistance is phenomena which 
following by several where is the discovery of antibiotics 
found the ability of very good adaptation for bacteria which 
is in therapy with several of antibiotic. So, the bacteria have 
the ability to mutation as mechanism of life survival [6 ]. 
This research is prevalence study to identify the 
existence of gen OXA as Carbapenem Resistance Encoders 
to Escherichia coli and Klebsiellapneumoniae with the 
method of Polymerase Chain Reaction (PCR) 
genotypically confirm the resistance cases in the hospital, 
especially in Dr. Mohammad Hoesin Palembang. The data 
is very important as the first information for the next 
research related with distribution of Gene blaOXA 
Resistance Encoders to Escherichia coli and Klebsiella 
pneumoniae. 
 
Materials and methods 
Methodology 
Type of research  
This research used the descriptive observational 
research with laboratory research design to identify gene 
OXA-48 with using PCR to Escherichia coli and Klebsiella 
Pneumoniae, Carbapenem resistance which isolate from 
the infection patient in RSUP Dr. Mohammad Hoesin 
Palembang. 
 
Time and place of research  
This research is implemented in the Molecular 
Biology Laboratorium of Medicine Faculty, Sriwijaya 
University Palembang and Microbiology Laboratorium of 
RSUP Dr. Mohammad Hoesin Palembang. 
 
Population and Sample of Research  
The population is the entire bacteria isolate 
Escherichia coli and Klebsiella pneumonia from the entire 
specimen types of carbapenem resistant infection patients 
which found in Microbiology Laboratorium of RSUP Dr. 
Mohammad Hoesin Palembang period of September-
November 2017. 
The data collection technique used purposive 
sampling Technique referred from the previous research 
implemented by Radhiyatul Husna, Deasy Nataliani and 
Rahmat M Usman of 2017. The isolated bacteria from 
infection patient which collected in the Department of 
Microbiology RSUP Dr. Mohammad Hosein Palembang 
and have identification as Escherichia coli and Klebsiella 
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pneumonia of Carbapenem resistance with using Vitek 2 
Compact which taken during period of 2017. 
 
Inclusion Criteria 
1. Isolate Bacteria of Escherichia coli and Klebsiella 
pneumonia which comes from the infection patient. 
2. Isolate Bacteria proven as Escherichia coli and 
Klebsiella pneumonia through the examination of culture 
and gram stain, and identified from Vitek 2 Compact. 
 
Procedure  
Identification of Carbapenem Resistant Escherichia Coli 
and Klebsiella Pneuomonia 
 Identification of resistance Carabapenem 
Escherichia coli dan Klebsiella pneuomonia implements 
using Vitek 2 Compact (bioMerieux, USA). This steps 
implemented by the previous research of 2017, there are 
the procedures as it explained below: 
1. Bacteria isolate is previously implemented the Gram 
Stain to determine the card will used. The test is 
implements to bacteria isolate which proven negative 
Gram. 
2. Added 3 mL of 0.45-0.5% sterile saline, pH 4.5-7.0 into 
a tube measuring 12 x 75 mm. 
3. Bacteria isolate added into a tube which contains saline 
solution with swab for making bacteria suspense. 
Suspension then homogenized with feculent 0,50-0,63 Mc 
Farland (for negative Gram Bacteria) with using VITEK 2 
DensiCHEK. 
4. Added to tube of bacteria suspense and VITEK 2 GN 
special crust card (cassette). 
5. Those rack then added into vacuum chamber station 
manually. Bacteria suspension removed into well by the 
tool and transfer tube cut automatically.  
6. The card is removed into the incubator room after 15 




Bacteria isolate have confirmed CRE then isolate by 
DNA. This step have implemented by the previous 
research of 2017. The way this is done is as follows: 
A. Tools and Materials 
1. Eppendorf tube 1,5 mL 
2. Pipettor with various size (10-100μL, and 100-1000 
μL) 
3. Pipet tip volume 100 μL 
4. Vortex 
5. ddH2O 
6. Phosphate Buffered Saline (PBS) 
7. Chelex 20% in ddH2O 
8. Micro centrifugal  
9. Water bath 
10. Freezer -20oC 
11. Saponins in 0,5% PBS 
12. Bacteria colony of Escherichia coli and Klebsiella 
pneumoniae are carbapenem resistant 
B. Procedures 
1. Provide sample to be tested, because sample is stored 
at cold temperature (-20oC), The sample must be left at 
room temperature before opening 
2. Gives the label eppendorf tube 1,5 mL, then added to 
the bacterial colony whose DNA will be isolated. 
3. Bacteria washed with 1mL PBS pH 7,4 then incubated 
during 10 minutes.  
4. Bacteria centrifugations with the speed of 5000 rpm 
during 5 minutes, remove the supernatant with a pipettor, 
this steps is repeated 3 times. 
5. Added 500 μL of 0,5% saponins in PBS, added in 
vortex in order to blended well. 
6. The mixture was incubated overnight at temperature -
20oC. 
7. In the next morning, the mixture was centrifuged at 
speed 12.000 rpm during 10 minutes, the supernatant is 
removed. 
8. Supernatant removed then added with 50 μLChelex 
20% in ddH2O pH 10,5 and added 100 μL ddH2O. 
9.  Added 50 μL Chelex 20% into ddH2O pH 10,5 and 
added 100 μLddH2O. 
10. The mixture was incubated in the boiled water during 
10 minutes. 
11. The centrifuged mixture with speed 12.000 rpm during 
10 minutes. 
12. Supernatant DNA moved into sterile eppendorf tube 
1,5 mL and stored in the temperature -20oC. 
 
Primary design  
 The primary design used to detect the OXA-48 
gene coding for Carbapenem resistance on Klebsiella 
pneuomoniae dan Escherichia coli which found in the 
study of [8]. It found two primary designs that used in the 
multiplex PCR research is forward sequent which used are 
5′-GCGTGGTTAAGGATGAACAC-3′reverse sequent 
which used 5′-CATCAAGTTCAACCCAACCG-3′. 
PCR gene OXA-48 
 The DNA isolation results are stored later in 
PCR to identify the presence or absence of the desired 
gene. In this research implemented PCR with using every 
primary gene OXA. Both result then compared to find 
whether or not there are bacteria that have these two genes 
together. 
A. Tools and Materials 
a. Eppendorf tube 0,2 and 1,5 Ml 
b. Pipettor with various size (10-100 μL, and 100-1000 
μL) 
c. Pipet tip volume 100 μL and 1000 μL 
d. Taq polymerase 
e. ddH2O 
f. transcription DNA from the DNA isolate result  
g. primer forward and reverse 
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Table 2 PCR Mixture Composition 
Materials Volume (μL) 
ddH2O 12 
Taq polymerase 8 
Primer forward 1 











PCR Product (bp) 
Forward 5′-GCGTGGTTAAGGATGAACAC-3′ 20  
477 Reverse 5′-CATCAAGTTCAACCCAACCG-3′ 20 
Sources: (8)  
 
B. Procedures  
1. Go Taq polymerase, ddH2O, Transcription DNA and 
Primary is poured with each volume multiplied by the 
number of samples poured in the eppendorf tube 1,5 mL 
used pipettor sized 100-1000 μL and pipet tip 1000 μL. It 
implemented the single PCR for gene OXA, it added so 
poured one by one primer for the gene to be tested. 
2. Moved the mixture into eppendorf tube 0,2 mL as much 
as the total sample with volume 25 μL every tube used 
pipettor sized 100-1000 μL and pipet tip 1000 μL. 
3. Added all into eppendorf tube 0,2 mL into PCR 
machine.  
4.  Implements the thermal temperature adjustment during 
PCR, with the temperature as follows: 
 
Table 4 Thermal Temperature Adjustment For Amplifications Process Gene OXA-48 
Gene Process Temperature Length Total 
cycles 
OXA-48 Initiation of 
cell lysis 
94ᵒC 10 minutes  
Denaturation 94ᵒC 30 second 36x 
Annealing 71ᵒC 40 second  
Extension 72ᵒC 50 second  
    
Final 
Extension 
72ᵒC 5 minutes  
Sources: (8)  
 
Electrophoresis Gel Agarose 
The PCR results then visualized by Agarose Gel 
Electroforesis. The procedure is implements as follows: 
A. Tools and Materials  
a. One set of electrophoresis tools 
b. Micropipette and tip 
c. Gel Doc 
d. Power Supply  
e. DNA Marker 
f. DNA Product 
g. Ethidium Bromide (EtBr) 
h. ddH2O 
i. Agarose Gel 
j. Loading Buffer (Loading Dye) 
k. Buffer Tri-acetate EDTA (TAE) 
 
B. Procedures 
Gel Agarose Making: 
1. Dissolve 0,4 gram of agarose powder into 50 ml buffer 
TAE by warming it up, after dissolve then let it sit in the 
temperature  ±50°C. 
2. Gel Comb installed into electrophoresis tanks. 
3. The solution agarose poured into electroforensis tanks 
and cooled until firm. 




1. Agrose gel soaked with TAE buffer. 
2. 1 µL loading dye mixed with 3 µL DNA product on 
parafilm that has been available with the help of a 
micropipette. 
3. The mixture is poured into well on the agarose gel. 
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4. While for 3µL DNA marker 1kb poured into well 
which it at the top and bottom edge. 
5. Electrophoresis tanks then closed and connected into 
power supply. Power supply (400mA, 90V) turned on for 
30 minutes. 
 
Data Processing and Analysis Plan 
 The data that obtained next will organized to 
simplify analysis. The data will be processed with using 
Microsoft Excel 2010 programs. The next analysis 
implemented with the simply statistic calculation in the 
form of percentage. The result from the data analysis will 
described in a narrative and presented in tabular form. 
 
Results and Discussion  
Result  
 The research related identification of the OXA-
48 gene encoding carbapenem resistance into Klebsiella 
pneumoniae and Escherichia coli will implements in the 
Laboratory of Biotechnology, Faculty of Medicine, 
Sriwijaya University and Microbiology Laboratory of Dr. 
Moh. Hoesin Palembang in 2017, total is 23 samples. 
 Detection of the phenotype of Klebsiella 
pneumoniae and Escherichia coli bacteria in the 
Microbiology Laboratory of Dr. Mohammad Hoesin 
Palembang using the Vitex 2 Compact bioMerieux, USA 
with assess the resistance antimicrobial MIC carbapenem 
on the Enterobacteriaceae Bacteria. After it implements 
the test to know the presence or absence of the OXA-48 
gene in bacteria Klebsiella pneumoniae and Escherichia 
coli with PCR method in Biotechnology Laboratorium, 
Faculty of Medicine, Sriwijaya University. 
 
Data Sample of Klebsiella Pneumoniae and Escherichia 
Coli 
 The sample which identification as Klebsiella 
pneumoniae and Escherichia coli with using Vitek 2 
Compact tools, it implemented the distribution which 
based on bacteria species. The result, shows that Klebsiella 
pneumonia bacteria is more was found, namely 15 (65.2%) 
while for Escherichia coli only 8 (34.8%) were found.  
 In the table 5 explains several specimens were 
taken for the purpose of supporting data in this research and 
calculate the specimens contained in this study obtained 
sample number 3 from positive urine specimens. 
Table 5 Distribution of OXA-48 on the Carbapenem Based On the Specimen Types 
 
No Specimen N Gen blaOXA-48 
Positive n (%) Negative n (%) 
1 Pus 4 0 0 4 100 
2 Sputum 9 0 0 8 100 
3 Urine 7 1 14,3 6 85,7 
4 Tissue 1 0 0 1 100 
5 Pleura fluid 1 0 0 1 100 
6 Swap the wound 1 0 0 1 100 
7 Feces 1 0 0 1 100 
Total 24     
 In the table 6, identification the Positive OXA-
48 Isolate from 24 tested isolate previously, after 
implementing electrophoresis and seen with UV light, 
identification based on base pair 477 bp obtained 1 isolate 
that was positive Carbapenem sensitive. 
 
Figure 1 Visualizes OXA-48 gene 
 
Annals of Mechnikov Institute, N 4, 2020 
www.imiamn.org.ua /journal.htm                                                                        60 
 
DOI: 10.5281/zenodo.4382206 
Table 6 Distribution of OXA-48 Gen in the samples 
Variable OXA-48 (+) OXA-48 (-) Total 
K. pneumoniae 1 14 15 
E. coli 0 8 8 
Total 1 22 23 
The sample sensitivity pattern on Antimicrobial based 
on Genotype blaOXA-48 
 The result of sample sensitivity based on 
Genotype blaOXA-48 can be seen from the table 10 found the 
significant difference in positive Klebsiella pneumoniae 
OXA-48 bacteria that 13 antibiotics Carbapenem only 
obtain gentamicin (Intermediate). While to Escherichia 
coli bacteria only obtain negative OXA-48. 
 This is shows that Gentamicin is still can be said 
to be successful in treatment even though its effectiveness 
is only moderate. 
 
Table 7 Sensitivity Pattern Klebsiella Pneumoniae on the Carbapenem of Various Antibiotics (N=15) 
Antibiotics 
Positive Gene OXA-48 
n (%) 
Negative Gene OXA-48  
n (%) 
R (%) I (%) S (%) R (%) I (%) S (%) 
Ampicillin  1 100 0 0 0 0 14 100 0 0 0 0 
Aztreonam 1 100 0 0 0 0 12 85,7 0 0 2 14,3 
Cefixime 1 100 0 0 0 0 12 85,7 0 0 2 14,3 
Amikacin 1 100 0 0 0 0 7 50 1 
 
7,1 6 43,9 
Ceftriaxone 1 100 0 0 0 0 12 85,7 0 0 2 14,3 
Cefazolin 1 100 0 0 0 0 12 85,7 0 0 2 14,3 
Ciprofloxacin 1 100 0 0 0 0 8 57,2 3 21,4 3 21,4 
Ceftazidime 1 100 0 0 0 0 12 85,7 0 0 2 14,3 
Gentamicin 0 0 1 100 0 0 10 71,4 0 0 4 28,6 
Nitrofurantoin 1 100 0 0 0 0 9 64,3 4 28,6 1 7,1 
Ertapenem 1 100 0 0 0 0 14 100 0 0 0 0 





100 0 0 0 0 13 
 
92,9 0 0 1 7,1 
 
Table 8 Sensitivity Pattern Escherichia Coli Carbapenem Resistant On the Several Antibiotic (N=8) 




 R % I % S % 
Ampicillin 8 100 0 0 0 0 
Aztreonam 4 50 0 0 4 50 
Cepefim 1 12,5 0 0 7 87,5 
Amikacin 1 87,5 0 0 7 87,5 
Ceftriaxone 3 37,5 0 0 5 62,5 
Cefazolin 3 37,5 0 0 5 62,5 
Ciprofloxacin 4 50 0 0 4 50 
Ceftazidime 3 37,5 0 0 5 62,5 
Gentamicin 3 37,5 0 0 5 62,5 
Nitrofurantoin 0 0 3 37,5 5 62,5 
Ertapenem 8 100 0 0 0 0 
Meropenem 8 100 0 0 0 0 
Ampicillin-Sulbactam 8 100 0 0 0 0 
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According to (4), since early 2000, 
carbapenemase Amble namely type KPC A or B class 
(enzyme IMP, VIM, and NDM) regarded as important 
carbapenemase in Enterobacteriaceae, because: 
1. Hydrolytic activity not only including carbapenem, but 
also broad spectrum cephalosporins; 
2. Carbapenemase activity is significant; 
3. The gene already in accordance identification around 
the world. 
Otherwise, OXA-48 not regarded as problem realizing: 
1. Hydrolytic spectrum is not including abroad spectrum 
cephalosporins  
2. Carbapenamase activity little low rather than with 
enzyme class A and B  
3. The spreading blaOXA-48 should have been confined 
to Turkey for years 
Despite the fact that blaOXA-48 is the part of 
functional transition, the spreading in accordance with 
plasmid supporting spreading and not from transposons. 
Another interesting observation in this connection with 
genetic context gene is similar with blaOXA-48 in 
accordance with the fact that all have identification in the 
relationship with insertion sequence, while most of class D 
gene b-lactamase is often identified. Although it closely 
related in the nucleotide sequence things, gene blaOXA-48 
always identified in the different context genetic (a 
transposon which made IS1999 or ISEcpl), shows that both 
gene is evolved each other with the mobilization of the 
different gene from two strains Shewanella donor [9]. 
From the research result above it known that 
found 1 positive sample (4,2%) blaOXA-48 gene 
genotype, which the sample also have OXA-48 gene. 
Meanwhile in U.S. is very rare to find as causes the 
resistance carbapenem case to the Enterobacteriaceae 
(10), OXA-48 first to be found in Turkey at 2001 [5]. It 
known in the research by [11] that cases OXA-48 located 
in Klebsiella pneumonia because of nosocomial infections 
in Turkey have the highest epidemiology level is Level 5 
with the status of an endemic situations. Meanwhile, in 
Spanish, France, Belgium and Romania the epidemiology 
level only reaches limited to level 4 with the spreading 
status is inter regional. 
Clinical consequences related with OXA-48 type 
of producer OXA-48 is quite important, because many of 
these producers classified as susceptible on Carbapenem in 
accordance with EUCAST guideline or CLSI [12]. 
Nowadays, the recommendation suggested by the 
guidelines are reported vulnerabilities on Carbapenem as 
found, regardless of whether the isolate produces 
carbapenemase or not. Recently, reported that imipenem 
can success used to treat bacteremias because 
K.pneumoniae is susceptible on the imipenem but 
produced OXA-48 [13]. 
The burden of antimicrobial resistance among 
Gram-negative pathogens, in particular resistant 
Enterobacteriaceae on carbapenem, it is increasing rapidly 
around the world. The treatment option for CRE infection 
then nowadays is still currently very limited. Dosage 
optimally and combination therapy are might be the most 
appropriate treatment strategy for now. However, the next 
researcher is suggested, particularly randomized controlled 




It has identified 1 sample is positive genotype 
blaOXA-48 from 24 samples comes from the patient 
infected patient in Muhammad Hoesin Hospital Palembang 
on September-November 2017 using PCR method. 
Suggestion  
1. The next research is needed for the clinical importance 
because still lacking the research related OXA-48 gene in 
Asian Part especially Indonesia on another 
Enterobacteriaceae. 
2. The next research is needed related with the connection 
between the sensitivity level and the associated gene. 
3. It needed deeper survey, broad and accurate from time 
related to antibiotics sensitivity pattern become as 
guidelines for determining the antibiotic of decision for 
doctor in the hospital. 
 
Identification of the Oxa-48 Gene Coding For 
Carbapenem Resistance in Klebsiella pneumoniae and 
Escherichia Coli at Dr. Muhammad Hoesin Central 
General Hospital, Palembang 
Muhammad Fitrizal 
OXA-48 is a class D β-lactamase which is not inhibited 
by clavulanic acid, tazobactam and sulbactam, because 
their activity may be inhibited in vitro by NaCl. Some b-
lactamase enzymes hydrolyze carbapenem and are 
therefore defined as hydrolysis of class D carbapenem b-
lactamase. Carbapenem-resistant Klebsiella pneumoniae 
isolates were found in Istanbul, Turkey, in 2001. OXA-48 
produces isolates that have the ability to fight drugs and 
cause very beneficial resistance to β-lactams, including 
widely available cephalosporins, cephamycins, and 
monobactone and carbapenem. The OXA-48 gene is 
found on plasmids. Antibiotic resistance is a phenomenon 
taken from the discovery of antibiotics where there is a 
very good adaptability for bacteria which are treated with 
various antibiotics. It has bacteria that have the ability to 
mutate as a protection for survival. This study is a case 
study involving the OXA gene as an encoder for 
carbapenem in Escherichia coli and Klebsiella 
pneumoniae using the Polymerase Chain Reaction (PCR) 
method to use genotypes used in hospitals that can be 
used in Dr. RSUP. Mohammad Hoesin Palembang. 
Bacterial isolates derived from patients with Klebsiella 
pneumoniae and Escherichia coli infections in the period 
September-November 2017 were identified using Vitek 2 
Compact. blaOXA-48 gene was detected by PCR, followed 
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by visualization through electrophoresis. The detection 
results were then analyzed by comparing the pattern of 
antibiotic resistance. From 24 samples tested only 1 
(4.7%) positive samples were obtained from the 
bacterium Klebsiellapneumoniae and no positive gene 
was found in Escherichia coli. This study identified 1 
(4.2%) samples that had a positive OXA-48 gene while 23 
(95.8%) samples had a negative OXA-48 gene. 
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